Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dennis Flannelly, Stephen Gunstream, Joseph Wagner

ReadCoor: Dennis Flannelly

Multi-omic spatial sequencing company ReadCoor has appointed Dennis Flannelly to its board of directors. Flannelly is currently head of precision medicine for US oncology at Merck, known as MSD outside of the US and Canada. Prior to joining Merck, Flannelly served in leadership roles at PerkinElmer, most recently as VP and general manager of the immunodiagnostics business, and previously as VP of maternal-fetal health. Flannelly has also served as global director of clinical marketing for Thermo Fisher Scientific’s immunodiagnostics business. He also served as the head of US marketing for Thermo Fisher.

Teknova: Stephen Gunstream

Teknova has appointed Stephen Gunstream as its CEO. Gunstream will replace Ted Davis, the firm's founder and retiring CEO. Gunstream previously served as VP and general manager of BD Biosciences' research and clinical business. Prior to BD, Gunstream served as chief commercial officer at Integrated DNA Technologies.

Notable: Joseph Wagner

Precision oncology company Notable has hired Joseph Wagner as CSO. A pharmacologist by training with a history in the biotech industry, Wagner had been executive director of the University of California Drug Discovery Consortium. He previously held executive positions at BriaCell Therapeutics, OncoCyte, and Cell Targeting. Wagner will report directly to Notable CEO Laurie Heilmann.

For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.

Filed under